-
Patent Agency Ranking
公开(公告)号：US20130172377A1
公开(公告)日：2013-07-04
申请号：US13773282
申请日：2013-02-21
Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Inventor： Ronald J. Christopher , Paul Covington , Atsushi Ogawa
IPC: A61K31/513
CPC classification number: A61K31/513 , A61K9/2018 , A61K31/426 , A61K31/44 , A61K38/26 , A61K45/06 , Y10S514/866 , A61K2300/00
Abstract: Pharmaceutical compositions and methods comprising 2-[6-(3-Amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl]-4-fluoro-benzonitrile or a pharmaceutically acceptable salt thereof administered once weekly.
Abstract translation: 药物组合物和方法包括2- [6-（3-氨基 - 哌啶-1-基）-3-甲基-2,4-二氧代-3,4-二氢-2H-嘧啶-1-基甲基] -4-氟 - 苄腈或其药学上可接受的盐。
-
公开(公告)号：US20180140589A1
公开(公告)日：2018-05-24
申请号：US15721342
申请日：2017-09-29
Applicant: Takeda Pharmaceutical Company Limited
Inventor： Ronald J. Christopher , Paul Covington
IPC: A61K31/4439 , A61K31/513 , A61K31/155 , A61K31/131 , A61K31/44 , A61K45/06
CPC classification number: A61K31/4439 , A61K31/131 , A61K31/155 , A61K31/44 , A61K31/513 , A61K45/06 , A61K2039/505 , C07C257/06 , C07C317/40 , C07C2602/08 , C07D209/26 , C07K16/2896 , C07K16/40 , C07K2317/76 , A61K2300/00
Abstract: Pharmaceutical compositions comprising 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile and pharmaceutically acceptable salts thereof in combination with metformin and in combination with pioglitazone.
-
公开(公告)号：US20190314352A1
公开(公告)日：2019-10-17
申请号：US16277537
申请日：2019-02-15
Applicant: Takeda Pharmaceutical Company Limited
Inventor： Ronald J. Christopher , Paul Covington
IPC: A61K31/4439 , C07K16/40 , A61K31/131 , A61K31/44 , C07D209/26 , C07C317/40 , C07C257/06 , A61K31/155 , A61K31/513 , C07K16/28 , A61K45/06
Abstract: Pharmaceutical compositions comprising 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1 (2H)-pyrimidinyl]methyl]-benzonitrile and pharmaceutically acceptable salts thereof are provided as well as kits and articles of manufacture comprising the pharmaceutical compositions as well as methods of using the pharmaceutical compositions.
-
公开(公告)号：US20140256757A1
公开(公告)日：2014-09-11
申请号：US14280942
申请日：2014-05-19
Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Inventor： Ronald J. Christopher , Paul Covington
IPC: A61K31/513 , A61K31/4439 , A61K31/155
CPC classification number: A61K31/4439 , A61K31/131 , A61K31/155 , A61K31/44 , A61K31/513 , A61K45/06 , A61K2039/505 , C07C257/06 , C07C317/40 , C07C2602/08 , C07D209/26 , C07K16/2896 , C07K16/40 , C07K2317/76 , A61K2300/00
Abstract: Pharmaceutical compositions comprising 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile and pharmaceutically acceptable salts thereof in combination with metformin and in combination with pioglitazone.
Abstract translation: 包含2 - [[6 - [（3R）-3-氨基-1-哌啶基] -3,4-二氢-3-甲基-2,4-二氧代-1（2H） - 嘧啶基]甲基] - 苄腈 和其药学上可接受的盐与二甲双胍组合并与吡格列酮组合。
-
公开(公告)号：US08906901B2
公开(公告)日：2014-12-09
申请号：US13773282
申请日：2013-02-21
Applicant: Takeda Pharmaceutical Company Limited
Inventor： Ronald J. Christopher , Paul Covington , Atsushi Ogawa
IPC: A61K31/00 , A61K38/26 , A61K45/06 , A61K31/44 , A61K31/426 , A61K31/513
CPC classification number: A61K31/513 , A61K9/2018 , A61K31/426 , A61K31/44 , A61K38/26 , A61K45/06 , Y10S514/866 , A61K2300/00
Abstract: Pharmaceutical compositions and methods comprising 2-[6-(3-Amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl]-4-fluoro-benzonitrile or a pharmaceutically acceptable salt thereof administered once weekly.
Abstract translation: 药物组合物和方法包括2- [6-（3-氨基 - 哌啶-1-基）-3-甲基-2,4-二氧代-3,4-二氢-2H-嘧啶-1-基甲基] -4-氟 - 苄腈或其药学上可接受的盐。
-
-
-
-
Search Results
5
records
(took 0.046 seconds)
